SEC Stock Data Quick Answer Addex Therapeutics Ltd. reported Total Assets of $10.68 million for fiscal year 2024. Addex Therapeutics Ltd. — Key Financials by Year Metric 2024 2023 2022 2021 2020 2019 Total Assets $10.68M+130.0% $4.64M-44.0% $8.28M-63.3% $22.54M+11.7% $20.18M-38.9% $33.03M-21.8% R&D Expense $854.3K-28.0% $1.19M-85.6% $8.24M-35.8% $12.84M+23.8% $10.37M-16.7% $12.45M+153.2% Addex Therapeutics Ltd. reported Total Assets of $10.68 million … Read more
Quick Answer Advanced Biomed Inc. reported Shares Outstanding of 21.64 million shares for fiscal year 2025. Advanced Biomed Inc. Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2025 21.64M +8.2% 2024 20.00M -80.0% 2024 100.00M +400.0% 2024 20.00M -80.0% 2023 100.00M — Quarterly Shares Outstanding Quarter Ending Shares Outstanding YoY QoQ December … Read more
Quick Answer Advanced Biomed Inc. reported R&D Expense of $909.8 thousand for fiscal year 2025. Advanced Biomed Inc. R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2025 $909.8K +3.4% 2024 $880.2K — Quarterly R&D Expense Quarter Ending R&D Expense YoY QoQ December 31, 2025 $186.3K -12.3% -21.0% September 30, 2025 $236.0K +29.9% … Read more
Quick Answer Advanced Biomed Inc. reported Stockholders Equity of $3.48 million for fiscal year 2025. Advanced Biomed Inc. Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 $3.48M +109.1% 2024 $1.66M +27.4% 2023 $1.31M — Quarterly Stockholders Equity Quarter Ending Stockholders Equity YoY QoQ December 31, 2025 $9.48M +1431.7% +215.6% September 30, … Read more
Quick Answer Advanced Biomed Inc. reported Total Assets of $6.51 million for fiscal year 2025. Advanced Biomed Inc. Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $6.51M +46.0% 2024 $4.46M — Quarterly Total Assets Quarter Ending Total Assets YoY QoQ December 31, 2025 $10.85M +140.9% +73.8% September 30, 2025 $6.24M — … Read more
Quick Answer Advanced Biomed Inc. reported Diluted EPS of $0.16 per share (loss) for fiscal year 2025. Advanced Biomed Inc. Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 -$0.16 -14.3% 2024 -$0.14 — Quarterly Diluted EPS Quarter Ending Diluted EPS YoY QoQ December 31, 2025 $0.31 +720.0% +1650.0% September 30, 2025 … Read more
Quick Answer Advanced Biomed Inc. reported Net Income of -$3.26 million for fiscal year 2025. Advanced Biomed Inc. Net Income — Annual History Fiscal Year Net Income YoY Change 2025 -$3.26M -17.1% 2024 -$2.78M — Quarterly Net Income Quarter Ending Net Income YoY QoQ December 31, 2025 $6.86M +855.4% +1872.5% September 30, 2025 -$386.9K -45.7% … Read more
Quick Answer Advanced Biomed Inc. reported Net Income of -$3.26 million for fiscal year 2025. Advanced Biomed Inc. — Key Financials by Year Metric 2025 2024 2023 Net Income -$3.26M-17.1% -$2.78M — Diluted EPS -$0.16-14.3% -$0.14 — Total Assets $6.51M+46.0% $4.46M — Stockholders Equity $3.48M+109.1% $1.66M+27.4% $1.31M R&D Expense $909.8K+3.4% $880.2K — Shares Outstanding 21.64M+8.2% … Read more
Quick Answer Advantage Solutions Inc. reported Shares Outstanding of 326.43 million shares for fiscal year 2025. Advantage Solutions Inc. Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2025 326.43M +1.8% 2024 320.77M -0.5% 2023 322.24M +0.8% 2022 319.69M +0.9% 2021 316.96M -0.5% 2020 318.43M +56.3% 2019 203.75M — Quarterly Shares Outstanding Quarter … Read more
Quick Answer Advantage Solutions Inc. reported Operating Income of -$126.47 million for fiscal year 2025. Advantage Solutions Inc. Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 -$126.47M +57.1% 2024 -$294.98M -733.2% 2023 $46.59M +103.1% 2022 -$1.49B -749.4% 2021 $230.05M +243.3% 2020 $67.01M -68.6% 2019 $213.67M +119.6% 2018 -$1.09B — Quarterly Operating … Read more